Full length articleControlling magnesium corrosion and degradation-regulating mineralization using matrix GLA protein☆

Add time:08/31/2019    Source:sciencedirect.com

Magnesium (Mg) alloys are embraced for their biodegradability and biocompatibility. However, Mg degrades spontaneously in the biological environment in vivo and in vitro, triggering deposition of calcium phosphate on the metal. Upon complete metal absorption, minerals remain in the tissue, which could lead to pathogenic calcification. Hence, our aims are to test the feasibility of matrix GLA protein (MGP) to locally inhibit Mg mineralization that is induced by metal alloy degradation. MGP is a small secretory protein that has been shown to inhibit soft tissue calcification. We exposed Mg to MGP, stably transfected into mammalian cells. Results showed that less calcium and phosphorous deposition on the Mg surface when MGP was present relative to when it was not. In the in vivo mouse intramuscular model conducted for 4 and 6 weeks, Mg rods were embedded in collagen scaffolds, seeded with cells overexpressing MGP. Microtomography, electron dispersive x-ray spectroscopy, and histology assessments revealed lower deposited mineral volume around Mg rods from the MGP group. Compared to other groups, higher volume loss after implantation was observed from the MGP group at both time points, indicating a higher corrosion rate without the protective mineral layer. This study is the first to our knowledge to demonstrate that local exposure to a biomolecule, such as MGP, can modulate the corrosion of Mg-based implants. These findings may have important implications for the future design of endovascular stents and orthopedic devices.

We also recommend Trading Suppliers and Manufacturers of GLA 60 (cas 111247-04-2). Pls Click Website Link as below: cas 111247-04-2 suppliers

Prev:Fabry disease caused by the GLA p.Phe113Leu (p.F113L) variant: Natural history in males
Next:Insuline glargine Gla-300 (Toujeo®) : de sa formulation à son utilisation en pratique cliniqueInsulin glargine Gla-300 (Toujeo®): From formulation to clinical practice)